Genetics

OpGen (NASDAQ:OPGN) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one common warrant to purchase one-half of a share of common stock. As quoted in the press release: The Company intends to use the net proceeds …

OpGen (NASDAQ:OPGN) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one common warrant to purchase one-half of a share of common stock.

As quoted in the press release:

The Company intends to use the net proceeds of this offering for research and development, including funding the continued development and manufacturing of its Acuitas® AMR Gene Panels, including its Acuitas AMR Gene Panel u5.47 that was released for Research Use Only in February 2018, support acquisitions of products and technologies, capital expenditures, working capital and other general corporate purposes.

Click here to read the full press release.

MARKETS

Markets
TSX19024.81-197.93
TSXV627.07-17.84
DOW30925.53-21.46
S&P 5003804.01-17.54
NASD11117.19-64.35
ASX6763.60+57.60

COMMODITIES

Commodities
Gold1818.95+0.38
Silver20.77-0.04
Copper3.780.00
Palladium1973.50+104.50
Platinum914.50+4.50
Oil111.71-0.05
Heating Oil4.02-0.09
Natural Gas6.51-0.06

DOWNLOAD FREE REPORTS

×